featured
Short-Term Efficacy of the Bifidobacterium Quadruple Viable Tablet in Patients With Diarrhea-Predominant IBS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The American Journal of Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Short-Term Efficacy of Bifidobacterium Quadruple Viable Tablet in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: Potentially Mediated by Metabolism Rather Than Diversity Regulation
Am. J. Gastroenterol 2023 Jul 01;118(7)1256-1267, T Bai, Z Xu, P Xia, Y Feng, B Liu, H Liu, Y Chen, G Yan, B Lv, Z Yan, N Dai, Y Long, W Wei, Z Shi, X Li, X Fang, H Gao, L Qi, X HouFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.